-
This week, we revealed that Aon/Willis Towers Watson are looking to separately divest a block of Willis' European businesses and Willis Re, as they work to get their mega merger approved by regulators in the face of competition concerns. -
The rejection was inevitable although the emphatic nature of it hints at a real determination to remain independent.
-
Independent agency distribution remains incredibly robust, despite the Covid-19 pandemic and the emergence of direct-to-consumer InsurTechs.
-
The broker upgraded its Q1 outlook with more optimism on later quarters, and increased confidence on margins and M&A.
-
As yet, the European Commission (EC) has not produced a formal State of Objections to Aon's proposed takeover of Willis Towers Watson following the Phase II competition probe it began in December.
-
The deal leaves Amwins, RSG and CRC with a market share of more than 80%, and it will be hard for anyone else to break in.
-
-
AIG’s shareholders are getting a raw deal, with an outcome on compensation that does not look like value for money.
-
Insurers face the difficult balancing act of signaling optimism to investors as they seek to push rate rises.
-
CEO Case has given insight here into how he hopes to win the battle for hearts and minds within the enlarged firm.
-
Hippo and Next Insurance are the top InsurTech candidates to go public this year.
